UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Simultaneous Quantification of Psychotropic Drugs in Human Plasma and Breast Milk and Its Application in Therapeutic Drug Monitoring and Peripartum Treatment Optimization

Therapeutic drug monitoring, 2024-04, Vol.46 (2), p.227-236

2024

Volltextzugriff (PDF)

UGT1A1 genotype and irinotecan therapy: general review and implementation in routine practice

Fundamental & clinical pharmacology, 2015-06, Vol.29 (3), p.219-237

2015

Volltextzugriff (PDF)

A Simple and Rapid UPLC‐UV Method for Detecting DPD Deficiency in Patients With Cancer

Clinical and translational science, 2020-07, Vol.13 (4), p.761-768

2020

Volltextzugriff (PDF)

Pharmacogenetics of anti-cancer drugs: State of the art and implementation – recommendations of the French National Network of Pharmacogenetics

Therapie, 2017-04, Vol.72 (2), p.205-215

2017

Volltextzugriff (PDF)

Validation of an electrospray ionization LC-MS/MS method for quantitative analysis of raltegravir, etravirine, and 9 other antiretroviral agents in human plasma samples

Therapeutic drug monitoring, 2009-12, Vol.31 (6), p.695-702

2009

Volltextzugriff (PDF)

Renal impairment and DPD testing: Watch out for false‐positive results

British journal of clinical pharmacology, 2022-11, Vol.88 (11), p.4928-4932

2022

Volltextzugriff (PDF)

Correlation between assessment of cytochrome P450 1A2 activity and enzyme activity scores, and their relation to clozapine exposure

British journal of clinical pharmacology, 2023-05, Vol.89 (5), p.1665-1671

2023

Volltextzugriff (PDF)

Pharmacogénétique des médicaments anticancéreux : état des connaissances et des pratiques – recommandations du Réseau national de pharmacogénétique (RNPGx)

Therapie, 2017-04, Vol.72 (2), p.193-204

2017

Volltextzugriff (PDF)

Traitements psychiatriques et pharmacogénétique

Actualités pharmaceutiques, 2022-05, Vol.61 (616), p.27-30

2022

Volltextzugriff (PDF)

Genetic polymorphism of the human cytochrome CYP2A13 in a French population: implication in lung cancer susceptibility

Biochemical and biophysical research communications, 2004-04, Vol.317 (2), p.662-669

2004

Volltextzugriff (PDF)

Pharmacogenetics of antidepressant drugs: State of the art and clinical implementation – recommendations from the French National Network of Pharmacogenetics

Therapie, 2017-04, Vol.72 (2), p.311-318

2017

Volltextzugriff (PDF)

Tacrolimus Exposure in Obese Patients: and A Case-Control Study in Kidney Transplantation

Therapeutic drug monitoring, 2021-04, Vol.43 (2), p.229-237

2021

Volltextzugriff (PDF)

Ledipasvir and tenofovir drug interaction in human immunodeficiency virus–hepatitis C virus coinfected patients: Impact on tenofovir trough concentrations and renal safety

British journal of clinical pharmacology, 2018-02, Vol.84 (2), p.404-409

2018

Volltextzugriff (PDF)

La pharmacogénétique, une discipline devenue incontournable

Actualités pharmaceutiques, 2022-05, Vol.61 (616), p.20-23

2022

Volltextzugriff (PDF)

Pharmacogénétique des médicaments antidépresseurs : état des connaissances et des pratiques – recommandations du Réseau national de pharmacogénétique (RNPGx)

Therapie, 2017-04, Vol.72 (2), p.301-309

2017

Volltextzugriff (PDF)

Lethal toxicities after capecitabine intake in a previously 5-FU-treated patient: why dose matters with dihydropryimidine dehydrogenase deficiency

Pharmacogenomics, 2019-08, Vol.20 (13), p.931-938

2019

Volltextzugriff (PDF)

La pharmacogénétique au service du soin en France : une discipline qui évolue

Therapie, 2020-09, Vol.75 (5), p.459-470

2020

Volltextzugriff (PDF)

Population pharmacokinetics and pharmacogenetics of vincristine in paediatric patients treated for solid tumour diseases

Cancer chemotherapy and pharmacology, 2011-11, Vol.68 (5), p.1191-1198

2011

Volltextzugriff (PDF)

Therapie

Therapie, 2017-04, Vol.72 (2), p.301-309

2017

Volltextzugriff (PDF)

Impact of plasma and intracellular exposure and CYP3A4, CYP3A5, and ABCB1 genetic polymorphisms on vincristine-induced neurotoxicity

Cancer chemotherapy and pharmacology, 2011-12, Vol.68 (6), p.1633-1638

2011

Volltextzugriff (PDF)

Estimated glomerular filtration rate but not solute carrier polymorphisms influences anemia in HIV–hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapy

AIDS (London), 2016-08, Vol.30 (13), p.2085-2090

2016

Volltextzugriff (PDF)

Triazole antifungal agents: practice guidelines of therapeutic drug monitoring and perspectives in treatment optimization

Annales de biologie clinique (Paris), 2014-07, Vol.72 (4), p.391-404

2014

Volltextzugriff (PDF)

Clinical application, limits and perspectives of pharmacogenetic and pharmacokinetic analysis of anticancer drugs

Annales de biologie clinique (Paris), 2014-09, Vol.72 (5), p.527-542

2014

Volltextzugriff (PDF)

ITPA deficiency and ribavirin level are still predictive of anaemia in HCV-HIV-coinfected patients receiving ribavirin combined with a first-generation DAA (ANRS HC27 study)

Antiviral therapy, 2017-01, Vol.22 (6), p.461-469

2017

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(55)
Bücher
(1)
Berichte
(1)

Sprache

Englisch
(31)
Französisch
(26)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Simultaneous Quantification of Psychotropic Drugs in Human Plasma and Breast Milk and Its Application in Therapeutic Drug Monitoring and Peripartum Treatment Optimization

UGT1A1 genotype and irinotecan therapy: general review and implementation in routine practice

A Simple and Rapid UPLC‐UV Method for Detecting DPD Deficiency in Patients With Cancer

Pharmacogenetics of anti-cancer drugs: State of the art and implementation – recommendations of the French National Network of Pharmacogenetics

Validation of an electrospray ionization LC-MS/MS method for quantitative analysis of raltegravir, etravirine, and 9 other antiretroviral agents in human plasma samples

Renal impairment and DPD testing: Watch out for false‐positive results

Correlation between assessment of cytochrome P450 1A2 activity and enzyme activity scores, and their relation to clozapine exposure

Pharmacogénétique des médicaments anticancéreux : état des connaissances et des pratiques – recommandations du Réseau national de pharmacogénétique (RNPGx)

Traitements psychiatriques et pharmacogénétique

Genetic polymorphism of the human cytochrome CYP2A13 in a French population: implication in lung cancer susceptibility

Pharmacogenetics of antidepressant drugs: State of the art and clinical implementation – recommendations from the French National Network of Pharmacogenetics

Tacrolimus Exposure in Obese Patients: and A Case-Control Study in Kidney Transplantation

Dihydropyrimidine déhydrogenase (DPD) deficiency screening and securing of fluoropyrimidine-based chemotherapies: Update and recommendations of the French GPCO-Unicancer and RNPGx networks

Ledipasvir and tenofovir drug interaction in human immunodeficiency virus–hepatitis C virus coinfected patients: Impact on tenofovir trough concentrations and renal safety

La pharmacogénétique, une discipline devenue incontournable

Pharmacogénétique des médicaments antidépresseurs : état des connaissances et des pratiques – recommandations du Réseau national de pharmacogénétique (RNPGx)

Lethal toxicities after capecitabine intake in a previously 5-FU-treated patient: why dose matters with dihydropryimidine dehydrogenase deficiency

La pharmacogénétique au service du soin en France : une discipline qui évolue

Population pharmacokinetics and pharmacogenetics of vincristine in paediatric patients treated for solid tumour diseases

Therapie

Impact of plasma and intracellular exposure and CYP3A4, CYP3A5, and ABCB1 genetic polymorphisms on vincristine-induced neurotoxicity

Estimated glomerular filtration rate but not solute carrier polymorphisms influences anemia in HIV–hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapy

Triazole antifungal agents: practice guidelines of therapeutic drug monitoring and perspectives in treatment optimization

Clinical application, limits and perspectives of pharmacogenetic and pharmacokinetic analysis of anticancer drugs

ITPA deficiency and ribavirin level are still predictive of anaemia in HCV-HIV-coinfected patients receiving ribavirin combined with a first-generation DAA (ANRS HC27 study)

Suchergebnisse filtern